Shemesh Shay

Chief Dev. &Ops. Officer | Chief Development Officer

1 company

Strong

Trades Analyzed

12M Win Rate

68.8%

Avg 3M Return

+14.7%

Avg 12M Return

+28.6%

Shemesh Shay is a Chief Dev. &Ops. Officer at Nuvectis Pharma, Inc.. Recent SEC Form 4 filings include 13 buys and 0 sells.

Estimated insider holdings value: $34.8M based on current market prices.

Holdings by Company

NVCTJan 6, 2026

Current Shares1.79M

Value$34.84M

Net Activity+11.4K

Bought: 11.4KSold: 0

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 10, 2024	NVCT Nuvectis Pharma, Inc.	Chief Dev. &Ops. Officer	Buy	1,113	$6.32	$7,034.16	-	+6.9%	+40.5%
Mar 21, 2023	NVCT Nuvectis Pharma, Inc.	Chief Dev. &Ops. Officer	Buy	420	$11.99	$5,035.80	-	+45.6%	-29.2%
Mar 15, 2023	NVCT Nuvectis Pharma, Inc.	Chief Dev. &Ops. Officer	Buy	670	$10.71	$7,175.70	-	+67.9%	-16.5%
Dec 21, 2022	NVCT Nuvectis Pharma, Inc.	Chief Dev. &Ops. Officer	Buy	500	$7.65	$3,825.00	-	+68.2%	+9.8%
Nov 17, 2022	NVCT Nuvectis Pharma, Inc.	Chief Dev. &Ops. Officer	Buy	300	$7.15	$2,145.00	-	+43.7%	+13.9%
Sep 23, 2022	NVCT Nuvectis Pharma, Inc.	Chief Dev. &Ops. Officer	Buy	220	$7.87	$1,731.40	-	-6.1%	+77.1%
Sep 2, 2022	NVCT Nuvectis Pharma, Inc.	Chief Dev. &Ops. Officer	Buy	404	$8.31	$3,357.24	-	-8.4%	+78.5%
Sep 1, 2022	NVCT Nuvectis Pharma, Inc.	Chief Dev. &Ops. Officer	Buy	3,006	$8.07	$24,258.42	+0.1%	-9.4%	+82.5%
May 20, 2022	NVCT Nuvectis Pharma, Inc.	Chief Dev. &Ops. Officer	Buy	300	$16.54	$4,962.00	-	-43.3%	+9.6%
May 17, 2022	NVCT Nuvectis Pharma, Inc.	Chief Dev. &Ops. Officer	Buy	242	$19.44	$4,704.10	-	-54.5%	-16.8%